Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
NVAX · against 446 other Healthcare companies of similar size
Ranked #445 of 447 · scores higher than 0% of peers · safety percentile 1
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)39 peers with a safety percentile of 0–9, including NVAX · Click a bar to see the companies
Mainly because of its debt / equity and beta, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | NVAX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 424 reported | Not reported | 0.21× | — | — | 33% |
| BetaLower is better · 418 reported | 2.44 | 0.50 | 2% | 33% | |
| Current ratioHigher is better · 433 reported | 2.33× | 2.80× | 45% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 1.5B USD | 100 | 44 | |
| 2 | 1.2B USD | 100 | 40 | |
| 3 | 2.6B USD | 100 | 43 | |
| 4 | 1.1B USD | 100 | ||
| 5 | 1.0B USD | 99 | 35 | |
| 441 | 2.0B USD | 2 | 27 | |
| 442 | 222.9B JPY (≈$1.5B) | 2 | 53 | |
| 443 | 1.2B CHF (≈$1.3B) | 1 | 28 | |
| 444 | 3.0B USD | 1 | 39 | |
| 445 | 1.6B USD | 1 | 7 | |
| 446 | 1.3B USD | 1 | 29 | |
| 447 | 2.9B USD | 1 | 50 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score